D'Argento, Ettore
 Distribuzione geografica
Continente #
NA - Nord America 962
AS - Asia 695
EU - Europa 547
SA - Sud America 177
AF - Africa 30
OC - Oceania 1
Totale 2.412
Nazione #
US - Stati Uniti d'America 931
SG - Singapore 353
CN - Cina 156
BR - Brasile 147
SE - Svezia 141
IT - Italia 108
DE - Germania 67
IN - India 61
VN - Vietnam 38
FR - Francia 34
IE - Irlanda 34
GB - Regno Unito 31
ID - Indonesia 25
FI - Finlandia 23
CA - Canada 17
RU - Federazione Russa 17
BE - Belgio 15
AR - Argentina 13
CI - Costa d'Avorio 12
MX - Messico 12
PL - Polonia 11
AT - Austria 10
CZ - Repubblica Ceca 10
NL - Olanda 10
UA - Ucraina 9
HK - Hong Kong 8
IR - Iran 8
IQ - Iraq 7
ZA - Sudafrica 7
ES - Italia 6
KR - Corea 6
BD - Bangladesh 5
JO - Giordania 5
JP - Giappone 5
LT - Lituania 5
TN - Tunisia 5
EC - Ecuador 4
RO - Romania 4
SA - Arabia Saudita 4
TR - Turchia 4
CH - Svizzera 3
CL - Cile 3
PE - Perù 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
CO - Colombia 2
DZ - Algeria 2
GR - Grecia 2
KE - Kenya 2
AL - Albania 1
AU - Australia 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
HR - Croazia 1
IL - Israele 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
MN - Mongolia 1
PH - Filippine 1
PK - Pakistan 1
PY - Paraguay 1
SN - Senegal 1
SV - El Salvador 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 2.412
Città #
Singapore 179
Chandler 171
Ashburn 95
New York 41
Beijing 34
Ann Arbor 33
Dublin 33
Los Angeles 33
Cattolica 32
The Dalles 31
Hyderabad 23
Rome 23
Jakarta 22
Boardman 21
San Mateo 21
Boston 19
Redmond 19
Hefei 18
Brussels 15
Munich 15
Wilmington 14
Moscow 13
Abidjan 12
Dallas 12
Dearborn 12
Frankfurt am Main 12
Ho Chi Minh City 12
Princeton 12
Marseille 11
Shanghai 11
Milan 10
São Paulo 10
Brno 9
Falls Church 9
Helsinki 9
Jacksonville 9
Santa Clara 9
Warsaw 9
Bremen 8
Buffalo 8
Nanjing 8
Hanoi 7
Hong Kong 7
Johannesburg 7
Brooklyn 6
Chicago 6
Düsseldorf 6
Falkenstein 6
Orem 6
Portsmouth 6
Seoul 6
Vienna 6
Amman 5
Chennai 5
Kent 5
Lappeenranta 5
Lawrence 5
London 5
Mexico City 5
Phoenix 5
Tokyo 5
Toronto 5
Atlanta 4
Denver 4
Fairfield 4
Houston 4
Montreal 4
Paris 4
Redwood City 4
Rio de Janeiro 4
Seattle 4
Shenyang 4
Stockholm 4
Andover 3
Bexley 3
Curitiba 3
Hebei 3
Lima 3
Miami 3
Nanchang 3
Newark 3
Norwalk 3
Riyadh 3
Tianjin 3
Turku 3
Ankara 2
Ardabil 2
Augusta 2
Baghdad 2
Bern 2
Cambridge 2
Campinas 2
Caratinga 2
City of London 2
Cuiabá 2
Des Moines 2
Dhaka 2
Embu das Artes 2
Erbil 2
Florianópolis 2
Totale 1.326
Nome #
Gastrointestinal stromal tumors (GISTs) and second malignancies A novel sentinel tumor? A monoinstitutional, STROBE-compliant observational analysis 154
Are TKIs favourable for the elderly with non-small-cell lung cancer? 140
Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory “FoRECATT” study 136
Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review. 115
ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis. 111
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non–small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors 111
Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis. 110
From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer? 109
Impact of Comprehensive Genome Profiling on the Management of Advanced Non–Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program 108
Oncogene-addicted non-small-cell lung cancer: Treatment opportunities and future perspectives 101
Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities 100
Molecular Testing in EBUS-TBNA Specimens of Lung Adenocarcinoma: A Study of Concordance Between Cell Block Method and Liquid-Based Cytology in Appraising Sample Cellularity and EGFR Mutations 99
Monoinstitutional real world experience in management of vinflunine as second line therapy for transitional cell carcinoma of the urothelium 99
Collagenous colitis and atezolizumab therapy: an atypical case. 97
Masaoka-koga and tnm staging system in thymic epithelial tumors: Prognostic comparison and the role of the number of involved structures 95
PD-L1 for selecting non-small-cell lung cancer patients for first-line immuno-chemotherapy combination: A systematic review and meta-analysis 94
Clinical Stage III NSCLC Patients Treated with Neoadjuvant Therapy and Surgery: The Prognostic Role of Nodal Characteristics 88
Exploring the molecular and biological background of lung neuroendocrine tumours 87
Percutaneous radiofrequency ablation using internally cooled wet electrodes for the treatment of patients with lung tumors 84
Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer? 82
Eficacy of topical beta-blockers in the management of EGFR-inhibitor induced paronychia and pyogenic granuloma-like lesions: Case series and review of the literature 78
The Role of Human Papilloma Virus (HPV) in Primary Lung Cancer Development: State of the Art and Future Perspectives 74
Multimodal therapy for synchronous bone oligometastatic NSCLC: The role of surgery 65
The interference between oxaliplatin & anti-EGFR therapies: A different hypothesis to explain the 'unexplainable' 64
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy 44
Totale 2.445
Categoria #
all - tutte 11.081
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.081


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202140 0 0 0 0 0 1 7 1 6 7 15 3
2021/2022186 26 3 1 29 10 8 2 25 9 6 22 45
2022/2023433 54 54 39 81 29 55 25 32 45 2 10 7
2023/2024217 2 59 5 9 5 23 17 14 3 12 22 46
2024/2025597 23 16 39 38 45 13 27 34 75 78 119 90
2025/2026760 181 31 72 201 259 16 0 0 0 0 0 0
Totale 2.445